Oncología médica
Specialty
Hospital Universitario Araba
Vitoria, EspañaPublications in collaboration with researchers from Hospital Universitario Araba (29)
2024
-
Baseline Circulating Blood Cell Counts and Ratios and Changes Therein for Predicting Immune-Related Adverse Events during Immune Checkpoint Inhibitor Therapy: A Multicenter, Prospective, Observational, Pan-Cancer Cohort Study with a Gender Perspective
Cancers, Vol. 16, Núm. 1
-
Impact of COVID-19 infection on genitourinary cancer management. SOGUG-COVID-19: A spanish, multicenter, observational study
Clinical and Translational Oncology
2022
-
Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients
Orphanet Journal of Rare Diseases, Vol. 17, Núm. 1
-
Prediction of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors With a Panel of Autoantibodies: Protocol of a Multicenter, Prospective, Observational Cohort Study
Frontiers in Pharmacology, Vol. 13
-
Urgent and unexpected findings in oncology and hematology patients: a practical approach to imaging
Radiologia, Vol. 64, Núm. 5, pp. 464-472
2021
-
Association between coffee consumption and total dietary caffeine intake with cognitive functioning: cross-sectional assessment in an elderly Mediterranean population
European Journal of Nutrition, Vol. 60, Núm. 5, pp. 2381-2396
-
Association of immune-related adverse events induced by nivolumab with a battery of autoantibodies
Annals of Medicine, Vol. 53, Núm. 1, pp. 762-769
-
Prognostic and therapeutic value of somatic mutations in diffuse large B-cell lymphoma: A systematic review
Critical Reviews in Oncology/Hematology, Vol. 165
2020
-
Cross-sectional association between non-soy legume consumption, serum uric acid and hyperuricemia: the PREDIMED-Plus study
European Journal of Nutrition, Vol. 59, Núm. 5, pp. 2195-2206
-
Probabilistic cost-utility analysis and expected value of perfect information for the Oncotype multigenic test: a discrete event simulation model
Gaceta Sanitaria, Vol. 34, Núm. 1, pp. 61-68
2019
-
Biological and prognostic differences between symptomatic colorectal carcinomas and those detected by screening
European Journal of Surgical Oncology, Vol. 45, Núm. 10, pp. 1876-1881
-
Cohort profile: Design and methods of the PREDIMED-Plus randomized trial
International Journal of Epidemiology, Vol. 48, Núm. 2, pp. 387-388o
-
Germline c.1A>C heterozygous pathogenic variant in SDHA reported for the first time in a young adult with a gastric gastrointestinal stromal tumour (GIST): A case report
Hereditary Cancer in Clinical Practice, Vol. 17, Núm. 1
-
Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients
Aging, Vol. 11, Núm. 9, pp. 2874-2888
-
Neoadjuvant metformin added to systemic therapy decreases the proliferative capacity of residual breast cancer
Journal of Clinical Medicine, Vol. 8, Núm. 12
-
Systematic review of the potential of MicroRNAs in diffuse large B cell lymphoma
Cancers, Vol. 11, Núm. 2
-
The C allele of ATM rs11212617 associates with higher pathological complete remission rate in breast cancer patients treated with neoadjuvant metformin
Frontiers in Oncology, Vol. 9, Núm. MAR
2018
-
A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: The METTEN study
Oncotarget, Vol. 9, Núm. 86, pp. 35687-35704
-
Circulating miRNAs as biomarkers in diffuse large B-cell lymphoma: A systematic review
Oncotarget, Vol. 9, Núm. 32, pp. 22850-22861
-
Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: Pooled analysis in 4 basque country university hospitals
ClinicoEconomics and Outcomes Research, Vol. 10, pp. 189-199